Literature DB >> 22652246

Cervical and anal human papillomavirus infection in adult women in American Samoa.

Brenda Y Hernandez1, Lana S Ka'opua, Luana Scanlan, John Ah Ching, Lori E Kamemoto, Pamela J Thompson, Xuemei Zhu, Yurii B Shvetsov, Jennifer Tofaeono, Victor Tofaeono Williams.   

Abstract

The prevalence of cervical and anal human papillomavirus (HPV) and risk factors associated with infections were evaluated in a cross-sectional study of 211 adult women in American Samoa. Overall, 53% of women reported ever having a Pap smear. Cervical and anal HPV was detected in 10% and 16% of women, respectively; 4% of women had concurrent cervical and anal HPV. The most common cervical genotypes were HPV 6, HPV 16, and HPV 53. Cutaneous HPV types were detected in 40% of anal infections. Cervical HPV infection was associated with anal HPV (age-adjusted odds ratio = 3.32, 1.10-10.00). After age adjustment, cervical HPV was associated with being unmarried, postsecondary education, hot running water at home, multiple sexual partners, nulliparity, condom use, and other contraceptive methods. In multivariate analyses, only age remained associated with cervical HPV and anal HPV. Cervical and anal HPV was more prevalent among younger women; only anal HPV was detected in older women.

Entities:  

Mesh:

Year:  2012        PMID: 22652246      PMCID: PMC4398572          DOI: 10.1177/1010539511410867

Source DB:  PubMed          Journal:  Asia Pac J Public Health        ISSN: 1010-5395            Impact factor:   1.399


  24 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 2.  Age-specific prevalence of infection with human papillomavirus in females: a global review.

Authors:  Jennifer S Smith; Amy Melendy; Rashida K Rana; Jeanne M Pimenta
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

3.  Anal human papillomavirus infection in women and its relationship with cervical infection.

Authors:  Brenda Y Hernandez; Katharine McDuffie; Xuemei Zhu; Lynne R Wilkens; Jeffrey Killeen; Bruce Kessel; Mark T Wakabayashi; Cathy C Bertram; David Easa; Lily Ning; Jamie Boyd; Christian Sunoo; Lori Kamemoto; Marc T Goodman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

4.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Prevalence of HPV infection among females in the United States.

Authors:  Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

Review 6.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

7.  Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.

Authors:  Salvatore Vaccarella; Silvia Franceschi; Rolando Herrero; Nubia Muñoz; Peter J F Snijders; Gary M Clifford; Jennifer S Smith; Eduardo Lazcano-Ponce; Sukhon Sukvirach; Hai-Rim Shin; Silvia de Sanjosé; Monica Molano; Elena Matos; Catterina Ferreccio; Pham Thi Hoang Anh; Jaiye O Thomas; Chris J L M Meijer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

8.  Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.

Authors:  Marc T Goodman; Yurii B Shvetsov; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Pamela J Thompson; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Brenda Y Hernandez
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

9.  Cancer in developing countries.

Authors:  D M Parkin
Journal:  Cancer Surv       Date:  1994

10.  Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study.

Authors:  Yurii B Shvetsov; Brenda Y Hernandez; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Marc T Goodman
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

View more
  8 in total

1.  Sequential Acquisition of Anal Human Papillomavirus (HPV) Infection Following Genital Infection Among Men Who Have Sex With Women: The HPV Infection in Men (HIM) Study.

Authors:  Shitaldas J Pamnani; Alan G Nyitray; Martha Abrahamsen; Dana E Rollison; Luisa L Villa; Eduardo Lazcano-Ponce; Yangxin Huang; Amy Borenstein; Anna R Giuliano
Journal:  J Infect Dis       Date:  2016-08-03       Impact factor: 5.226

2.  Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.

Authors:  Chunqing Lin; Jiri Slama; Paula Gonzalez; Marc T Goodman; Ningshao Xia; Aimée R Kreimer; Ting Wu; Nancy A Hessol; Yurii Shvetsov; Ana P Ortiz; Beatriz Grinsztejn; Anna-Barbara Moscicki; Isabelle Heard; María Del Refugio González Losa; Erna M Kojic; Maarten F Schim van der Loeff; Feixue Wei; Adhemar Longatto-Filho; Zizipho A Mbulawa; Joel M Palefsky; Annette H Sohn; Brenda Y Hernandez; Katina Robison; Steve Simpson; Lois J Conley; Alexandra de Pokomandy; Marianne A B van der Sande; Racheal S Dube Mandishora; Lays P B Volpini; Alessandra Pierangeli; Byron Romero; Timothy Wilkin; Silvia Franceschi; Carmen Hidalgo-Tenorio; Reshmie A Ramautarsing; Ina U Park; Fernanda K Tso; Sheela Godbole; Kathleen W M D'Hauwers; Borek Sehnal; Lynette J Menezes; Sandra A Heráclio; Gary M Clifford
Journal:  Lancet Infect Dis       Date:  2019-06-13       Impact factor: 25.071

3.  Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.

Authors:  J Obel; J McKenzie; L E Buenconsejo-Lum; A M Durand; A Ekeroma; Y Souares; D Hoy; W Baravilala; S M Garland; S K Kjaer; A Roth
Journal:  Asian Pac J Cancer Prev       Date:  2015

Review 4.  EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.

Authors:  Anna R Giuliano; Alan G Nyitray; Aimée R Kreimer; Christine M Pierce Campbell; Marc T Goodman; Staci L Sudenga; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2014-07-26       Impact factor: 7.396

Review 5.  Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.

Authors:  Elizabeth A Stier; Meagan C Sebring; Audrey E Mendez; Fatimata S Ba; Debra D Trimble; Elizabeth Y Chiao
Journal:  Am J Obstet Gynecol       Date:  2015-03-19       Impact factor: 8.661

6.  Human papillomavirus genotypes in Pacific Islander cervical cancer patients.

Authors:  T M Schisler; A K Bhavsar; B P Whitcomb; J H Freeman; M A Washington; J W Blythe; M A Nahid; C S Dietrich
Journal:  Gynecol Oncol Rep       Date:  2018-04-18

7.  Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy.

Authors:  Maria Nasioutziki; Kimon Chatzistamatiou; Panagiotis-Dimitrios Loufopoulos; Eleftherios Vavoulidis; Nikolaos Tsampazis; George-Chrysostomos Pratilas; Anastasios Liberis; Vasiliki Karpa; Evanggelos Parcharidis; Angelos Daniilidis; Konstantinos Spanos; Konstantinos Dinas
Journal:  Infect Agent Cancer       Date:  2020-04-15       Impact factor: 2.965

8.  Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico.

Authors:  A P Ortiz; J Romaguera; C M Pérez; D González; C Muñoz; L González; E Marrero; G Tortolero-Luna; E Suárez; J Palefsky
Journal:  Papillomavirus Res       Date:  2016-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.